SLC5A2 and cyst: SGLT-2 inhibitors reduce sodium reabsorption in the proximal tubules, activating the TGF mechanism to lower glomerular filtration rate and filtration pressure, relieving local high-pressure states, reducing kidney unit damage and compensatory hypertrophy, which may slow the progression of renal parenchymal damage and cyst expansion (122).